8 results
8-K
MLYS
Mineralys Therapeutics, Inc.
14 Jun 24
Departure of Directors or Certain Officers
8:06am
Officers; Compensatory Arrangements of Certain Officers.
On June 13, 2024, upon the recommendation of the Nominating and Corporate Governance Committee … of the Company, the Board appointed Alexander M. Gold, M.D. as a member of the Board and the Nominating and Corporate Governance Committee of the Board. Dr. Gold
DEF 14A
MLYS
Mineralys Therapeutics, Inc.
9 Apr 24
Definitive proxy
7:15am
and corporate governance committee of our board of directors, is Jon Congleton. On March 29, 2024, Alexander Asam, Ph.D., who is currently a Class I … and venture capital firms. The process undertaken by the nominating and corporate governance committee in recommending qualified director candidates
8-K
MLYS
Mineralys Therapeutics, Inc.
14 Sep 23
Departure of Directors or Certain Officers
4:11pm
of the Board to eight (8) members. On the Effective Date, upon the recommendation of the Nominating and Corporate Governance Committee of the Board … . The members of the nominating and corporate governance committee are now Brian Taylor Slingsby, M.D., Ph.D., M.P.H., Dr. Asam and Olivier Litzka, Ph.D
DRS/A
MLYS
Mineralys Therapeutics, Inc.
29 Dec 22
Draft registration statement (amended)
12:00am
listing requirements of Nasdaq, such as the corporate governance requirements or the minimum closing bid price requirement, Nasdaq may take steps to delist … establishment and maintenance of effective disclosure and financial controls and certain corporate governance practices. Further, pursuant to the Dodd-Frank
DRS/A
tzchjfa2owc390emu
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
rhh 3j7fj
4 Nov 22
Draft registration statement
12:00am
DRS
EX-4.2
4b7ny47v 48iueldi
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next